ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/07/2026
Voltar para busca
Dado oficial do USPTO
INTODEWORLD
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
01/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42
Data de depósito
14/09/2016
Data de registro
11/12/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
19/03/2025
Última transação
01/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
701
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
01/10/2016
Primeiro uso no comércio
01/10/2016
Código do desenho
4
Tipo de titular
03
Localização do titular
GYEONGGI-DO, KR
Examinador
PEETE, KYLE C
Localização atual
Historical data usage
Titulares e representantes
Titulares
INTRON BIOTECHNOLOGY, INC.
iNtODEWORLD, Inc.
iNtODEWORLD, Inc.
iNtODEWORLD, Inc.
Representantes
Feng Shan SIMI Law Group, P.C.
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Research and development and consultation related thereto in the field of novel drug discovery and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of technology in the field of novel drug discovery and development; Research in the field of chemistry; Research in the field of novel drug discovery and development; Research on food; Research on the subject of pharmaceuticals; Researchdevelopmentengineering and testing services in the fields of immunopharmaceuticals and vaccines; Agricultural research; Bacteriological research; Bacteriological research and testing; Bacteriological consultation and research; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical research; Conducting clinical trials for others; Cosmetics research; Cosmetics research for others; DNA analysis services for scientific research purposes; DNA screening for scientific research purposes; Drugalcohol and DNA screening for forensic research purposes; Food research; Genetic testing for scientific research purposes; Laboratory research in the field of novel drug discovery and development; Laboratory research services relating to pharmaceuticals; Mechanical research; Medical research; Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of novel drug discovery and development; Medical and scientific research information in the field of novel drug discovery and development; Pharmaceutical research and development; Pharmaceutical research services; Product research; Providing laboratory research services in the field of gene expressioncancer biology; Providing medical research and scientific research information in the field of oncology via the Internet; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific research; Scientific research and development; Scientific research consulting in the field of cosmetics; Scientific research consulting in the field of novel drug discovery and development; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of novel drug discovery and development; Scientific research in the field of genetics and genetic engineering; Technical research in the field of pharmaceutical studies; Testinginspectionresearchdevelopment of pharmaceutical preparations for gene therapy; Web-based cardiovascular research and analysis services for scientific purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
19/03/2025
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
19/03/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
19/03/2025
E815
TEAS SECTION 8 & 15 RECEIVED
21/11/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/12/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/12/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/11/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/11/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
28/09/2018
IUAF
USE AMENDMENT FILED
26/09/2018
EISU
TEAS STATEMENT OF USE RECEIVED
26/09/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/08/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
27/04/2018
EX2G
SOU EXTENSION 2 GRANTED
26/04/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
24/04/2018
NREV
NOTICE OF REVIVAL - E-MAILED
10/04/2018
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
09/04/2018
PETG
PETITION TO REVIVE-GRANTED
09/04/2018
PROA
TEAS PETITION TO REVIVE RECEIVED
09/04/2018
EXT2
SOU EXTENSION 2 FILED
28/03/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
28/09/2017
EX1G
SOU EXTENSION 1 GRANTED
26/09/2017
EXT1
SOU EXTENSION 1 FILED
26/09/2017
EEXT
SOU TEAS EXTENSION RECEIVED
26/09/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
28/03/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
24/03/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31/01/2017
PUBO
PUBLISHED FOR OPPOSITION
31/01/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/01/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/12/2016
DOCK
ASSIGNED TO EXAMINER
19/12/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/09/2016
NWAP
NEW APPLICATION ENTERED
17/09/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace INTODEWORLD ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.